Literature DB >> 29802365

Advances in the research and development of therapeutic antibodies against the Zika virus.

Shibo Jiang1,2, Lanying Du3.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29802365      PMCID: PMC6318303          DOI: 10.1038/s41423-018-0043-x

Source DB:  PubMed          Journal:  Cell Mol Immunol        ISSN: 1672-7681            Impact factor:   11.530


× No keyword cloud information.
  10 in total

1.  Congenital Zika Syndrome in 2017.

Authors:  Daniel Lucey; Hannah Cummins; Sabrina Sholts
Journal:  JAMA       Date:  2017-04-04       Impact factor: 56.272

2.  Specificity, cross-reactivity, and function of antibodies elicited by Zika virus infection.

Authors:  Karin Stettler; Martina Beltramello; Diego A Espinosa; Victoria Graham; Antonino Cassotta; Siro Bianchi; Fabrizia Vanzetta; Andrea Minola; Stefano Jaconi; Federico Mele; Mathilde Foglierini; Mattia Pedotti; Luca Simonelli; Stuart Dowall; Barry Atkinson; Elena Percivalle; Cameron P Simmons; Luca Varani; Johannes Blum; Fausto Baldanti; Elisabetta Cameroni; Roger Hewson; Eva Harris; Antonio Lanzavecchia; Federica Sallusto; Davide Corti
Journal:  Science       Date:  2016-07-14       Impact factor: 47.728

3.  Molecular determinants of human neutralizing antibodies isolated from a patient infected with Zika virus.

Authors:  Qihui Wang; Huabing Yang; Xiaoqing Liu; Lianpan Dai; Tong Ma; Jianxun Qi; Gary Wong; Ruchao Peng; Sheng Liu; Junfu Li; Shihua Li; Jian Song; Jianying Liu; Jianhua He; Hui Yuan; Ying Xiong; Yong Liao; Jianhua Li; Jianping Yang; Zhou Tong; Bryan D Griffin; Yuhai Bi; Mifang Liang; Xiaoning Xu; Chuan Qin; Gong Cheng; Xinzheng Zhang; Peiyi Wang; Xiangguo Qiu; Gary Kobinger; Yi Shi; Jinghua Yan; George F Gao
Journal:  Sci Transl Med       Date:  2016-12-14       Impact factor: 17.956

4.  Structural Basis of Zika Virus-Specific Antibody Protection.

Authors:  Haiyan Zhao; Estefania Fernandez; Kimberly A Dowd; Scott D Speer; Derek J Platt; Matthew J Gorman; Jennifer Govero; Christopher A Nelson; Theodore C Pierson; Michael S Diamond; Daved H Fremont
Journal:  Cell       Date:  2016-07-27       Impact factor: 41.582

5.  Neutralizing human antibodies prevent Zika virus replication and fetal disease in mice.

Authors:  Gopal Sapparapu; Estefania Fernandez; Nurgun Kose; Julie M Fox; Robin G Bombardi; Haiyan Zhao; Christopher A Nelson; Aubrey L Bryan; Trevor Barnes; Edgar Davidson; Indira U Mysorekar; Daved H Fremont; Benjamin J Doranz; Michael S Diamond; James E Crowe
Journal:  Nature       Date:  2016-11-07       Impact factor: 49.962

6.  A Human Bi-specific Antibody against Zika Virus with High Therapeutic Potential.

Authors:  Jiaqi Wang; Marco Bardelli; Diego A Espinosa; Mattia Pedotti; Thiam-Seng Ng; Siro Bianchi; Luca Simonelli; Elisa X Y Lim; Mathilde Foglierini; Fabrizia Zatta; Stefano Jaconi; Martina Beltramello; Elisabetta Cameroni; Guntur Fibriansah; Jian Shi; Taylor Barca; Isabel Pagani; Alicia Rubio; Vania Broccoli; Elisa Vicenzi; Victoria Graham; Steven Pullan; Stuart Dowall; Roger Hewson; Simon Jurt; Oliver Zerbe; Karin Stettler; Antonio Lanzavecchia; Federica Sallusto; Andrea Cavalli; Eva Harris; Shee-Mei Lok; Luca Varani; Davide Corti
Journal:  Cell       Date:  2017-09-21       Impact factor: 41.582

7.  Structure of the thermally stable Zika virus.

Authors:  Victor A Kostyuchenko; Elisa X Y Lim; Shuijun Zhang; Guntur Fibriansah; Thiam-Seng Ng; Justin S G Ooi; Jian Shi; Shee-Mei Lok
Journal:  Nature       Date:  2016-04-19       Impact factor: 49.962

8.  Neutralizing human monoclonal antibodies prevent Zika virus infection in macaques.

Authors:  Diogo M Magnani; Thomas F Rogers; Nathan Beutler; Michael J Ricciardi; Varian K Bailey; Lucas Gonzalez-Nieto; Bryan Briney; Devin Sok; Khoa Le; Alexander Strubel; Martin J Gutman; Núria Pedreño-Lopez; Nathan D Grubaugh; Cassia G T Silveira; Helen S Maxwell; Aline Domingues; Mauricio A Martins; David E Lee; Erica E Okwuazi; Sherrie Jean; Elizabeth A Strobert; Ann Chahroudi; Guido Silvestri; Thomas H Vanderford; Esper G Kallas; Ronald C Desrosiers; Myrna C Bonaldo; Stephen S Whitehead; Dennis R Burton; David I Watkins
Journal:  Sci Transl Med       Date:  2017-10-04       Impact factor: 17.956

9.  A human antibody against Zika virus crosslinks the E protein to prevent infection.

Authors:  S Saif Hasan; Andrew Miller; Gopal Sapparapu; Estefania Fernandez; Thomas Klose; Feng Long; Andrei Fokine; Jason C Porta; Wen Jiang; Michael S Diamond; James E Crowe; Richard J Kuhn; Michael G Rossmann
Journal:  Nat Commun       Date:  2017-03-16       Impact factor: 14.919

10.  Neutralization of Zika virus by germline-like human monoclonal antibodies targeting cryptic epitopes on envelope domain III.

Authors:  Yanling Wu; Shun Li; Lanying Du; Chunyu Wang; Peng Zou; Binbin Hong; Mengjiao Yuan; Xiaonan Ren; Wanbo Tai; Yu Kong; Chen Zhou; Lu Lu; Xiaohui Zhou; Shibo Jiang; Tianlei Ying
Journal:  Emerg Microbes Infect       Date:  2017-10-11       Impact factor: 7.163

  10 in total
  4 in total

1.  Potent germline-like monoclonal antibodies: rapid identification of promising candidates for antibody-based antiviral therapy.

Authors:  Xiaoyi Zhu; Fei Yu; Yanling Wu; Tianlei Ying
Journal:  Antib Ther       Date:  2021-05-17

2.  Transfusion-Transmitted Zika Virus Infection in Pregnant Mice Leads to Broad Tissue Tropism With Severe Placental Damage and Fetal Demise.

Authors:  Wanbo Tai; Denis Voronin; Jiawei Chen; Weili Bao; Debra A Kessler; Beth Shaz; Shibo Jiang; Karina Yazdanbakhsh; Lanying Du
Journal:  Front Microbiol       Date:  2019-01-23       Impact factor: 5.640

3.  Rational Design of Zika Virus Subunit Vaccine with Enhanced Efficacy.

Authors:  Wanbo Tai; Jiawei Chen; Yusen Zhou; Fang Li; Lanying Du; Guangyu Zhao; Qibin Geng; Lei He; Yuehong Chen
Journal:  J Virol       Date:  2019-08-13       Impact factor: 5.103

Review 4.  Structural Biology Illuminates Molecular Determinants of Broad Ebolavirus Neutralization by Human Antibodies for Pan-Ebolavirus Therapeutic Development.

Authors:  Charles D Murin; Pavlo Gilchuk; James E Crowe; Andrew B Ward
Journal:  Front Immunol       Date:  2022-01-10       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.